{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:19Z","timestamp":1792801879270,"version":"4.5.0"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:p>Preeclampsia is associated with significant perinatal morbidity and mortality. Aspirin has been long purported and extensively studied for prevention of preeclampsia. For this reason, the U.S. Preventive Services Task Force, the American College of Obstetricians and Gynecologists, and the Society for Maternal-Fetal Medicine recommend its use in pregnancy for preeclampsia prevention in those at high risk. Yet, much controversy exists regarding optimal use in pregnancy with guidelines across global organizations varying. In this narrative review, we summarize the published literature related to the safety, optimal dose, and timing and duration of use of aspirin, as well as other indications for which aspirin has been studied in pregnancy.<\/jats:p>","DOI":"10.1097\/aog.0000000000005429","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:22:28Z","timestamp":1698945748000},"page":"1333-1340","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Aspirin in Pregnancy"],"prefix":"10.1097","volume":"142","author":[{"given":"Maura","family":"Jones Pullins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Flint","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,2]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia. ACOG Practice Bulletin No. 222. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"Low-dose aspirin use during pregnancy. ACOG Committee Opinion No. 743. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"695","DOI":"10.7326\/M13-2844","article-title":"Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force","volume":"160","author":"Henderson","year":"2014","journal-title":"Ann Intern Med"},{"key":"R5-20260916","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004659.pub3","article-title":"Antiplatelet agents for preventing preeclampsia and its complications","author":"Duley","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/1471-0528.15386","article-title":"Care of women with obesity in pregnancy: Green-Top Guideline No. 72","volume":"126","author":"Denison","year":"2019","journal-title":"BJOG"},{"issue":"suppl 1","key":"R10-20260916","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of preeclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2023.0691","article-title":"Aspirin discontinuation at 24 to 28 weeks' gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial","volume":"329","author":"Mendoza","year":"2023","journal-title":"JAMA"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)93025-7","article-title":"Aspirin and congenital malformations","volume":"1","author":"Slone","year":"1976","journal-title":"Lancet"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/AOG.0000000000001301","article-title":"Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses","volume":"127","author":"Ahrens","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R15-20260916","first-page":"551","article-title":"Low-dose aspirin in pregnancy","volume":"74","author":"Sibai","year":"1989","journal-title":"Obstet Gynecol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1471-0528.1995.tb10872.x","article-title":"Low dose aspirin in pregnancy and early childhood development: follow up of the Collaborative Low Dose Aspirin Study in Pregnancy: CLASP collaborative group","volume":"102","year":"1995","journal-title":"Br J Obstet Gynaecol"},{"key":"R17-20260916","first-page":"1122","article-title":"Hypertension in pregnancy: report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"819","DOI":"10.7326\/M14-1884","article-title":"Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement: US Preventive Services Task Force","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"R20-20260916","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm preeclampsia [published erratum appears in Ultrasound Obstet Gynecol 2017;50:807]","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1471-0528.17370","article-title":"Preterm and term preeclampsia: relative burdens of maternal and perinatal complications","volume":"130","author":"von Dadelszen","year":"2023","journal-title":"BJOG"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"e2130804","DOI":"10.1001\/jamanetworkopen.2021.30804","article-title":"Use of a smartphone app to explore potential underuse of prophylactic aspirin for preeclampsia","volume":"4","author":"Krishnamurti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R27-20260916","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/AOG.0000000000003631","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis [letter]","volume":"135","author":"Cuckle","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"e022056","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for preeclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/AOG.0000000000003167","article-title":"A nudge toward universal aspirin for preeclampsia prevention","volume":"133","author":"Ayala","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"e2142343","DOI":"10.1001\/jamanetworkopen.2021.42343","article-title":"Estimated prevalence of risk factors for preeclampsia among individuals giving birth in the US in 2019","volume":"5","author":"Wheeler","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20260916","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1055\/s-0040-1718580","article-title":"Improving utilization of aspirin for prevention of preeclampsia in a high-risk urban cohort: a prospective cohort study","volume":"38","author":"Boelig","year":"2021","journal-title":"Am J Perinatol"},{"key":"R34-20260916","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women: CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R35-20260916","doi-asserted-by":"crossref","first-page":"612.e1","DOI":"10.1016\/j.ajog.2018.02.014","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit","volume":"218","author":"Wright","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20260916","article-title":"Antiplatelet agents for preventing preeclampsia and its complications [published update appears in The Cochrane Database of Systematic Reviews 2019;2019:CD004659]","author":"Duley","year":"2007","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R37-20260916","doi-asserted-by":"crossref","first-page":"101000","DOI":"10.1016\/j.ajogmf.2023.101000","article-title":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R38-20260916","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"R39-20260916","first-page":"334","article-title":"Aspirin resistance may be associated with adverse pregnancy outcomes","volume":"32","author":"W\u00f3jtowicz","year":"2011","journal-title":"Neuro Endocrinol Lett"},{"key":"R40-20260916","doi-asserted-by":"crossref","first-page":"385.e1","DOI":"10.1016\/j.ajog.2019.01.222","article-title":"Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin","volume":"220","author":"Finneran","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R41-20260916","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"R42-20260916","doi-asserted-by":"crossref","first-page":"255.e1","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R43-20260916","first-page":"1","article-title":"Increases in prepregnancy obesity: United States, 2016-2019","author":"Driscoll","year":"2020","journal-title":"NCHS Data Brief"},{"key":"R44-20260916","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R45-20260916","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"30","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"R46-20260916","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R47-20260916","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"R48-20260916","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial [published erratum appears in Lancet 2020;395:e53]","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"R49-20260916","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajog.2016.10.016","article-title":"Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis","volume":"216","author":"Meher","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R50-20260916","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","article-title":"The Society for Obstetric Anesthesia and Perinatology consensus statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants","volume":"126","author":"Leffert","year":"2018","journal-title":"Anesth Analg"},{"key":"R51-20260916","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine evidence-based guidelines (fourth edition) [published erratum appears in Reg Anesth Pain Med 2018;43:566]","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"key":"R52-20260916","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/HYPERTENSIONAHA.109.134825","article-title":"Time-dependent effects of low-dose aspirin on plasma renin activity, aldosterone, cortisol, and catecholamines","volume":"54","author":"Snoep","year":"2009","journal-title":"Hypertension"},{"key":"R53-20260916","first-page":"B2","article-title":"Society for Maternal-Fetal Medicine Consult Series #52: diagnosis and management of fetal growth restriction: (replaces clinical guideline number 3, April 2012)","volume":"223","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R54-20260916","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ogc.2011.12.003","article-title":"Tocolytic therapy for acute preterm labor","volume":"39","author":"Abramovici","year":"2012","journal-title":"Obstet Gynecol Clin North Am"},{"key":"R55-20260916","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/aje\/kwp131","article-title":"Placental vascular pathology findings and pathways to preterm delivery","volume":"170","author":"Kelly","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R56-20260916","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9378(93)90499-9","article-title":"Maternal placental vasculopathy and infection","volume":"168","author":"Arias","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"R57-20260916","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/AOG.0000000000001848","article-title":"Antiplatelet agents and the prevention of spontaneous preterm birth: a systematic review and meta-analysis","volume":"129","author":"Van Vliet","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R58-20260916","doi-asserted-by":"crossref","first-page":"399.e1","DOI":"10.1016\/j.ajog.2018.06.011","article-title":"Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women","volume":"219","author":"Andrikopoulou","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R59-20260916","doi-asserted-by":"crossref","first-page":"e1003892","DOI":"10.1371\/journal.pmed.1003892","article-title":"Evaluation of low-dose aspirin in the prevention of recurrent spontaneous preterm labour (the APRIL study): a multicentre, randomised, double-blinded, placebo-controlled trial","volume":"19","author":"Landman","year":"2022","journal-title":"PLoS Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:03:11Z","timestamp":1789556591000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,2]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005429","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,2]]},"assertion":[{"value":"2023-06-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}